NDC 83831-145 – Avopef
Etoposide 500 mg/25mL · Injection · Intravenous
Product NDC83831-145
Product details
- Brand name
- Avopef
- Generic name
- Etoposide
- Labeler
- AVYXA Pharma, LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- NDA · NDA220200
- Marketed since
- September 14, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Etoposide 500 mg/25mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 83831-145-25 | 1 VIAL in 1 CARTON (83831-145-25) / 25 mL in 1 VIAL | Sep 14, 2026 |
Other Avopef products
- 83831-144 Etoposide 100 mg/5mL · Injection · AVYXA Pharma, LLC